After Success Against COVID-19 Variants, Novavax Will File Vaccine First In UK

Efficacy Lower Against South Africa Strain

 
• By Andrew McConaghie
South African community healthcare workers
THE TRIALS IN THE UK AND SOUTH AFRICA MEANT NOVAVAX IS THE FIRST TO TEST A VACCINE AGAINST THE NEW SARS-COV2 VARIANTS FIRST IDENTIFIED IN THESE COUNTRIES.

More from Europe

More from Geography